Previous Article | Next Article 
Journal of Clinical Microbiology, April 1999, p. 1107-1112, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Strain Variation in Adenovirus Serotypes 4 and 7a
Causing Acute Respiratory Disease
Leta K.
Crawford-Miksza,1,*
Roberto N.
Nang,2 and
David P.
Schnurr1
Viral and Rickettsial Disease Laboratory,
Division of Communicable Disease Control, California State Department
of Health Services, Berkeley, California 94704,1
and U.S. Army Center for Health Promotion and Preventive
Medicine, Aberdeen Proving Ground, Maryland
210102
Received 5 August 1998/Returned for modification 30 September
1998/Accepted 18 November 1998
In order to determine the suitability of vaccine strains
established in the 1960s for a new vaccine, a comprehensive study of
strain variation of adenovirus serotype 4 (AV 4) and AV 7 was undertaken. A 1,500-bp region of the hexon gene containing the AV
neutralization epitopes from prototype, vaccine, and community-acquired strains and from wild-type strains from military personnel that cause
acute respiratory disease (ARD) was sequenced and analyzed. The whole
hexon gene from prototype strains, vaccine strains, and selected
isolates was sequenced. AV 7 and AV 7a were found to have distinct
genotypes, and all vaccine and wild-type strains recovered from 1963 to
1997 had the AV 7a genotype. There was no significant strain variation
in the neutralization epitopes of the AV 7a genotype over a 42-year
period. The evolution of AV 4 was more complex, with continuous genetic
drift punctuated by replacement with a new strain. The current strain
of AV 4, which has been in circulation since 1995, is significantly
different from the AV 4 prototype and the vaccine strains. Genetic
differences were confirmed to be antigenic differences by
neutralization tests, which define the new strain as an AV 4 variant. A
type-specific PCR for AV 4, AV 7/7a, and AV 21 was developed, and this
PCR facilitated the rapid identification of isolates from outbreaks of ARD.
*
Corresponding author. Mailing address: Viral and
Rickettsial Disease Laboratory, California Department of Health
Services, 2151 Berkeley Way, Berkeley CA 94704. Phone: (510) 540-2560. Fax: (510) 540-3305.
Journal of Clinical Microbiology, April 1999, p. 1107-1112, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ebner, K., Rauch, M., Preuner, S., Lion, T.
(2006). Typing of Human Adenoviruses in Specimens from Immunosuppressed Patients by PCR-Fragment Length Analysis and Real-Time Quantitative PCR.. J. Clin. Microbiol.
44: 2808-2815
[Abstract]
[Full Text]
-
Madisch, I., Harste, G., Pommer, H., Heim, A.
(2005). Phylogenetic Analysis of the Main Neutralization and Hemagglutination Determinants of All Human Adenovirus Prototypes as a Basis for Molecular Classification and Taxonomy. J. Virol.
79: 15265-15276
[Abstract]
[Full Text]
-
Ebner, K., Pinsker, W., Lion, T.
(2005). Comparative Sequence Analysis of the Hexon Gene in the Entire Spectrum of Human Adenovirus Serotypes: Phylogenetic, Taxonomic, and Clinical Implications. J. Virol.
79: 12635-12642
[Abstract]
[Full Text]
-
Purkayastha, A., Su, J., McGraw, J., Ditty, S. E., Hadfield, T. L., Seto, J., Russell, K. L., Tibbetts, C., Seto, D.
(2005). Genomic and Bioinformatics Analyses of HAdV-4vac and HAdV-7vac, Two Human Adenovirus (HAdV) Strains That Constituted Original Prophylaxis against HAdV-Related Acute Respiratory Disease, a Reemerging Epidemic Disease. J. Clin. Microbiol.
43: 3083-3094
[Abstract]
[Full Text]
-
Krafft, A. E., Russell, K. L., Hawksworth, A. W., McCall, S., Irvine, M., Daum, L. T., Connoly, J. L., Reid, A. H., Gaydos, J. C., Taubenberger, J. K.
(2005). Evaluation of PCR Testing of Ethanol-Fixed Nasal Swab Specimens as an Augmented Surveillance Strategy for Influenza Virus and Adenovirus Identification. J. Clin. Microbiol.
43: 1768-1775
[Abstract]
[Full Text]
-
Purkayastha, A., Ditty, S. E., Su, J., McGraw, J., Hadfield, T. L., Tibbetts, C., Seto, D.
(2005). Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development. J. Virol.
79: 2559-2572
[Abstract]
[Full Text]
-
Jacobs, S. C., Davison, A. J., Carr, S., Bennett, A. M., Phillpotts, R., Wilkinson, G. W. G.
(2004). Characterization and manipulation of the human adenovirus 4 genome. J. Gen. Virol.
85: 3361-3366
[Abstract]
[Full Text]
-
Blasiole, D. A., Metzgar, D., Daum, L. T., Ryan, M. A. K., Wu, J., Wills, C., Le, C. T., Freed, N. E., Hansen, C. J., Gray, G. C., Russell, K. L.
(2004). Molecular Analysis of Adenovirus Isolates from Vaccinated and Unvaccinated Young Adults. J. Clin. Microbiol.
42: 1686-1693
[Abstract]
[Full Text]
-
Xu, W., McDonough, M. C., Erdman, D. D.
(2000). Species-Specific Identification of Human Adenoviruses by a Multiplex PCR Assay. J. Clin. Microbiol.
38: 4114-4120
[Abstract]
[Full Text]